Castillo-Sánchez José Carlos, Cerrada Alejandro, Conde Mikel, Cruz Antonio, Pérez-Gil Jesús
Department of Biochemistry and Molecular Biology, Faculty of Biology, and Research Institute "Hospital 12 de Octubre (imas12)", Complutense University, Madrid, Spain.
Department of Biochemistry and Molecular Biology, Faculty of Biology, and Research Institute "Hospital 12 de Octubre (imas12)", Complutense University, Madrid, Spain.
Biochim Biophys Acta Biomembr. 2022 Feb 1;1864(1):183808. doi: 10.1016/j.bbamem.2021.183808. Epub 2021 Oct 20.
Lung surfactant (LS) stabilizes the respiratory surface by forming a film at the alveolar air-liquid interface that reduces surface tension and minimizes the work of breathing. Typically, this surface-active agent has been isolated from animal lungs both for research and biomedical applications. However, these materials are constituted by complex membranous architectures including surface-active and inactive lipid/protein assemblies. In this work, we describe the composition, structure and surface activity of discrete membranous entities that are part of a LS preparation isolated from bronchoalveolar lavages of porcine lungs. Seven different fractions could be resolved from whole surfactant subjected to sucrose density gradient centrifugation. Detailed compositional characterization revealed differences in protein and cholesterol content but no distinct saturated:unsaturated phosphatidylcholine ratios. Moreover, no significant differences were detected regarding apparent hydration at the headgroup region of membranes, as reported by the probe Laurdan, and lipid chain mobility analysed by electron spin resonance (ESR) in spite of the variety of membranous assemblies observed by transmission electron microscopy. In addition, six of the seven separated LS subfractions formed similar, essentially disordered-like, interfacial films and performed efficient surface activity, under physiologically relevant conditions. Altogether, our work show that a LS isolated from porcine lungs is comprised by a heterogenous population of membranous assemblies lacking freshly secreted unused LS complexes sustaining highly dehydrated and ordered membranous assemblies as previously reported. We propose that surfactant subfractions may illustrate intermediates in sequential structural steps within the structural transformations occurring along the respiratory compression-expansion cycles.
肺表面活性剂(LS)通过在肺泡气液界面形成一层膜来稳定呼吸表面,该膜可降低表面张力并使呼吸功最小化。通常,这种表面活性剂已从动物肺中分离出来用于研究和生物医学应用。然而,这些材料由复杂的膜结构组成,包括表面活性和非活性脂质/蛋白质组装体。在这项工作中,我们描述了从猪肺支气管肺泡灌洗物中分离出的LS制剂的离散膜实体的组成、结构和表面活性。通过蔗糖密度梯度离心可从整个表面活性剂中分离出七种不同的组分。详细的成分表征揭示了蛋白质和胆固醇含量的差异,但没有明显的饱和:不饱和磷脂酰胆碱比率。此外,尽管通过透射电子显微镜观察到各种膜组装体,但用探针Laurdan报道的膜头基区域的表观水合作用以及通过电子自旋共振(ESR)分析的脂质链流动性方面未检测到显著差异。此外,在生理相关条件下,七个分离的LS亚组分中的六个形成了相似的、基本上无序的界面膜并表现出高效的表面活性。总之,我们的工作表明,从猪肺中分离出的LS由异质的膜组装体群体组成,缺乏如先前报道的维持高度脱水和有序膜组装体的新分泌未使用的LS复合物。我们提出,表面活性剂亚组分可能说明了沿呼吸压缩-膨胀周期发生的结构转变中连续结构步骤的中间体。